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Purpose: Replication error is an important mechanism in carcinogenesis. The microsatellite instability (MSI-H) of colorectal cancers is 
associated with the development of multiple cancers. The influence of MSI-H on the development of multiple gastric cancers in sporadic 
gastric cancer patients has not been defined. This study was performed to reveal the association between the clinicopathologic features 
and MSI in sporadic gastric cancers. 
Materials and Methods: Between July 2004 and March 2009, the clinicopathologic characteristics, including MSI status, were evalu-
ated in 128 consecutive patients with sporadic gastric cancers. None of the patients had hereditary non-polyposis colorectal cancer of 
familial gastric cancer. The markers that were recommended by the NCI to determine the MSI status for colorectal cancers were used. 
Results: MSI-H cancers were found in 10.9% of the patients (14/128). Synchronous gastric cancers were shown in 4 patients (3.1%). 
Synchronous cancers were found in 2 of 14 patients with MSI-H gastric cancer (14.3%) and 2 of 114 patients with MSS gastric cancer 
(1.8%; P=0.059, Fisher’s exact test). Among the patients with synchronous cancer 50% (2/4) had MSI-H cancer, but 9.7% of the pa-
tients (12/124) without synchronous cancer had MSI-H cancer. MSI-H (RR, 24.7; 95% CI, 1.5~398.9; P=0.024) was related with to 
synchronous gastric cancer, but age, gender, family history, histologic type, location, gross morphology, size, and stage were not related 
to synchronous gastric cancer. 
Conclusions: MSI is associated with the intestinal-type gastric cancer and the presence of multiple gastric cancers in patients with spo-
radic gastric cancer. Special attention to the presence of synchronous and the development of metachronous multiple cancer in patients 
with MSI-H gastric cancer is needed.
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Introduction
Attention has recently focused on the role of microsatellite in-
stability (MSI) in the development of digestive tract cancer, and 
a number of studies have been conducted on the association with 
clinicopathologic features. MSI has been reported to be closely 
associated with hereditary non-polypopsis colorectal cancer 
(HNPCC). MSI is detected in approximately 15% of patients with 
non-HNPCC.(1) In patients with MSI, the incidence of metachro-
nous colon cancer is increased.(2) In gastric cancer, MSI is shown 
in 7~50% cases.(3) Multiple gastric cancer is detected in  4~15% of 
all gastric cancer patients.(4) Nevertheless, in gastric cancer patients, 
it is not clear whether or not multiple development is associated 
with hereditary factors. It has been shown that the development of 
metachronous gastric cancer is more frequent in multiple gastric 
cancer than single gastric cancer.(5) Therefore, by the examination 
of genetic factors associated with multiple gastric cancer, develop-
ment of metachronous cancer could be predicted, and the early diag-
nosis by appropriate screening tests could be anticipated. A high fre-Kim SH, et al.
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quency of MSI was observed in multiple gastric cancer in comparison 
with single gastric cancer, which suggests an association.(6) In Korea, 
studies on MSI have not been conducted, and thus we examined 
the clinicopathologic characteristics of gastric cancer, including the 
association of MSI with multiple gastric cancer.
Materials and Methods
1. The patients
One hundred twenty-eight patients who were diagnosed with 
gastric cancer between July 2004 and November 2009, underwent 
surgical resection, and were pathologically-diagnosed with gastric 
adenocarcinoma were enrolled in the study. Eighty-eight patients 
were male and 40 patients were female. The mean age of the patients 
was 60.57±11.80 years. Eighty-six patients had advanced gastric 
cancer and 42 patients had early gastric cancer. Gastric adenocar-
cinoma was classified according to the Japanese Gastric Cancer 
Association (JGCA) classification as well differentiated, moderately 
differentiated, poorly differentiated, mucinous, and signet ring cell.
(7) According to Lauren’s classification, gastric adenocarcinoma was 
classified as intestinal, diffuse, and mixed.(8) For the determination 
of the stage of gastric cancer, the AJCC cancer staging manuals (6th 
edition) was applied. By examining the medical records of patients 
and the results of histologic tests, age, gender, tumor site, macro-
scopic classification, and tumor size and stage were evaluated. The 
family history was obtained by telephone interviews, and patients 
with a family history of gastric cancer or HNPCC were excluded. 
Based on the time of diagnosis, patients diagnosed at the same time 
or within 6 months were considered to be synchronous cancer, and 
cases diagnosed 6 months after the diagnosis of primary cancer 
were classified as metachronous cancer.(9) The mean duration of 
follow-up was 4.12±1.13 years. During the follow-up period, none 
of patients developed metachronous gastric cancer or secondary 
cancers in other organs.
2. Sampling and DNA extraction
Tissue slides of 128 patients were examined under a light mi-
croscope, and DNA was extracted from normal and tumor tissues 
of tissue sections stained with HE. The tissues were sonicated in 
600 μl of nucleic lysis solution, and the lysate was collected and in-
cubated at 65
oC for approximately 30 minutes. Three microliters of 
RNase was added and incubated again at 37
oC for approximately 30 
minutes. Two hundred microliters of protein precipitation solution 
was added, centrifuged, the supernatant was discarded, 70% ethanol 
was added, centrifuged, and the pellets were dried. DNA was dis-
solved by adding 100 μl of DNA rehydration solution. PCR was 
performed with the solution containing 60 ng of genomic DNA, 2 
pmol each primers, 50 mM KCL, 10 mM Tris, 0.4 mM dNTP, 1.5 
mM MgCl2, and 0.6 unit Taq DNA polymerase (Promega, Madison, 
Fitchburg, WI, USA). The final volume was 10 μl. As the first step 
of PCR, the initial denaturation was performed for 5 minutes at 
94
oC, and 30 cycles of the procedure, 94
oC for 1 minute, 55
oC for 
1 minute, 72
oC for 1 minute, and the final amplification procedure 
72
oC for 10 minutes. Amplified product (0.7 μl) was added to the 
mixture of 0.3 μl Genescan 500 size standard and 9 μl of HiDi for-
mamide, and analyzed by an ABI Prism 3100 Genetic analyzer.
3. Analysis of MSI
BAT25 and BAT26 with the repeated sequence of a single 
nucleotide, and D5S346, D2S123, and D17S250 with the repeated 
Fig. 1. An example of PCR analysis of microsatellite instability. Tumor DNA shows alterations of allele lengths in BAT25, BAT26, D5S346, D2S123, 
and D17S250. ▼ = arrow heads indicate microsatellite instability. Microsatellite instability is associated with the clinicopathologic features of gastric 
cancer in sporadic gastric cancer patients.Clinicopathologic Features of MSI-H Gastric Cancer
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sequence of two nucleotides, were selected as PCR primers for the 
assessment of MSI.(10) The microsatellite loci were amplified by 
PCR using radiolabeled oligonucleotide primers, the length was 
analyzed by gel electrophoresis or autoradiography, and the dif-
ference between normal tissues and cancer tissues was examined. 
With respect to MSI, if the DNA of tumor tissues show new bands 
in comparison with normal tissues, it was considered to be MSI. 
The loss of an allelic gene was not considered to be MSI (Fig. 1). 
In our study, according to the guideline of the National Cancer 
Institute (Bethesda, Maryland, MD, USA), 5 markers were se-
lected. Cases positive for ＞2 markers were considered to be high-
frequency MSI (MSI-H), while cases positive for ＜2 markers were 
considered to be low-frequency MSI (MSI-L) or microsatellite 
stable (MSS).(11) Only MSI-H was considered to be the satellite 
instability group, and MSI-L or MSS was referred to as the satellite 
stability group.
4. Data analysis and statistics
In the comparison of clinicopathologic characteristics for uni-
variate analysis, a chi-square test was performed; for multivariate 
analysis, multivariate logistic regression analysis was performed. 
Among univariate factors, age and tumor size were consecutive 
variables, and other variables were categorical. The common analy-
sis factors for multivariate analysis were gender and age.(12) In the 
current study, MSI, the location of the tumor, disease stages re-
ported to be statistically significant in other studies,(13) differentia-
tion,(14) and advanced or early gastric cancer were included. SPSS 
(ver. 17.0; SPSS, Inc., Chicago, IL, USA) was used. A P-value＜0.05 
was considered to be statistically significant.
Results
One hundred twenty-eight gastric cancer patients underwent 
gastrectomies and were diagnosed by histologic evaluation; MSI 
was detected in 14 patients (10.9%) and 114 patients (89.1%) were 
in the MSS group. Four patients (3.1%) had multiple gastric can-
cer and 124 patients (96.8%) had single gastric cancer. In Lauren’s 
classification of the MSI group, 8 patients had the intestinal type, 1 
patient had the diffuse type, and 5 patients had the mixed type. In 
the MSS group, 61 patients had the intestinal type, 43 patients had 
the diffuse type, and 10 patients had the mixed type. In the MSI 
group, intestinal-type gastric cancer was dominant, and a signifi-
cant difference between MSI-H and MSI-L was shown (P=0.004). 
Age, gender, and clinical factors, such as family history, tumor size, 
tumor location, lymph node metastasis, distant metastasis, and gross 
findings, did not show any difference between MSI-H and MSI-L 
(Table 1).
Among the 14 patients in the MSI group, 2 patients (14.3%) had 
multiple gastric cancer. Among the 114 patients in the MSS group, 
2 patients (1.8%) had multiple gastric cancer. Of the 4 patients with 
multiple gastric cancer, 2 (50%) had MSI. Based on logistic regres-
sion analysis, only MSI was shown to be an independent risk factor 
associated with the development of multiple gastric cancer (P=0.024; 
RR, 24.71; 95% CI, 1.532~98.857) (Table 2). In multiple gastric 
cancer, the rate of MSI was 50%, which was shown to be signifi-
cantly higher than single gastric carcinoma (9.6%).
Discussion
The mechanism by which gastric cancer develops is a multi-step 
process. Indeed, cancer develops by the accumulation of genetic or 
environmental changes inducing the dysfunction of genes.(15) The 
Table 1. Clinicopathologic characteristics of gastric cancers positive for microsatellite instability
Variables R.R.
95.0% C.I. for R.R.
P-value
Lower Upper
Age
Gender
0.999
1.558
0.884
0.083
1.129
29.332
0.986
0.767
Gross
Stage
12.770
4.312
0.160
0.245
1,020.905
75.360
0.255
0.318
Diff  erentiation  0.340 0.001 12.628 0.091
Microsatellite instability 24.719 1.532 398.857 0.024
Location 25.089 0.585 1,076.15 0.093
R.R. = relative risk; C.I. = confi  dence interval.Kim SH, et al.
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genetic mechanisms involved in the development of gastric cancer 
include mutations or inactivation of various tumor suppressor genes. 
Nevertheless, genetic instability is the most basic change, as well 
as an essential factor. Gastric cancer exhibits particular clinical and 
pathologic characteristics depending on the presence or absence 
of microsatellite changes, and thus the molecular biological char-
acteristics of gastric cancer is assessed by examining microsatellite 
changes. 
In the MSI group, genetic changes accumulate and exert effects 
on the multistep tumor development process. Thus, the incidence of 
multiple cancer, such as HNPCC is high. Among the characteristic 
of HNPCC, genetic instability is associated with the development 
of multiple colon carcinoma.(2) Therefore, the same theory could 
be applied to gastric cancer, which is one of the organs prefer-
entially developing HNPCC, although it has not been proven.(16) 
In other words, in sporadic gastric cancer, systemic studies on the 
genetic factors inducing multiple gastric cancer have not been con-
ducted. Numerous studies on the role of the mismatch repair (MMR) 
of DNA during the oncogenic process of gastric cancer have been 
reported; however, the results are contradictory in many cases, and 
since factors involved in the oncogenesis are abundant, definitive 
conclusions cannot be drawn.
MSI is detected in 10~45% gastric cancer, reflecting differ-
ences in definition of MSI.(17) Specifically, in previous studies on 
MSI of gastric cancer, diverse definitions of MSI have been ap-
plied, such as the 5 NCI consensus markers,(10) or BAT-26.(18) In 
colorectal cancer, the consensus is the standard of markers chosen 
by the National Cancer Institute in 1977 (BAT25, BAT26, D5S346, 
D2S123, and D17S250). In the current study, according to the 
guidelines of the National Cancer Institute, the presence or absence 
of MSI was defined. In the low-frequency MSI group, clinical dif-
ferences from the MSS group were not detected. Noticeable differ-
ences of the high-frequency MSI group from the two groups were 
detected from the clinical features and survival rate.(19) Therefore, 
MSI-H could be considered as MSI-positive gastric cancer. Simi-
larly, in the current study, only MSI-H was classified as the MSI 
group. The results show that among 128 gastric cancer cases, only 
14 patients (10.9%) had MSI, which is comparable to the incidence 
reported in other studies. Although the guidelines of the National 
Cancer Institute for colorectal cancer were followed, among 14 pa-
tients in the MSI group, 13 patients were positive for the BAT-26 
marker that has been shown to determine the phenotype of MSI, 
and it is considered that the criteria of the MSI-H group selected in 
our study were sufficient to be classified as the MSI group. 
Table 2. Multivariate logistic regression analysis for the variables 
associated with synchronous cancers in the patients with gastric 
cancer
Characteristics
Total
(N=128)
MSI+
(N=14)
MSI−
(N=114)
P-value
Mean age (yr) 63.64±9.95 60.19±12.00 0.304
Gender   0.131
   Male
   Female
Family history
   Absent
   Present
     88
40
100
28
        7
7
11
3
        81
        33
89
25
0.794
Location
   Lower
   Middle
   Upper 
99
     27
      2
12
1
 1
87
26
1
0.094
Gross type 1.000
   Advanced
   Early
     87
     41
       10
4 
        77
37
Size(cm)  6.32±3.53 4.83±2.65 0.069
Multiplicity 4 2 2 0.059
Lauren’s classifi  cation
   Intestinal
   Diff  use
   Mixed
 69
44
15
8
1
5
61
43
10
 0.004
Diff  erentiation
   Well
   Moderate
   Poor
   Signet ring cell
17
51
50
10
2
8
4
0
15
43
46
10
0.429
T
    Serosa-negative
    Serosa-positive
73
55
9
5
64
50
0.776
N
    Node-negative
    Node-positive
47
81
4
10
43
71
0.571
M                       
    0
    1
   
124
4
13
1
111
3
0.374
Stage  
    I
    II
    III
    IV
  
45
23
42
18
      
4
4
5
1
41
19
37
17
0.609
         
         
         
         
MSI+ = high-frequency microsatellite instability; MSI− = low-
frequency microsatellite instability or microsatellite stability.Clinicopathologic Features of MSI-H Gastric Cancer
153
In the current study, four cases of multiple gastric cancer were 
all double tumors, thus the number of total tumors was eight. MSI 
of all tumors was tested, and even if MSI was detected in only 
one tumor, the case was classified as MSI. Among the 4 cases (8 
tumors), MSI-H was detected in 2 tumors (25%) in 2 cases (50%), 
and in the cases of multiple cancer, all individual tumors were 
MSI-H were not detected. This was interpreted to be that un-
der the same environmental and genetic backgrounds in multiple 
cancer, the mechanisms underlying tumor suppressor genes and 
mutations for each tumor acted differently and induced individual 
tumors, and the sum was shown as multiple tumors. This implies 
the heterogeneity of MSI in multiple gastric cancer, and other stud-
ies also have shown a similar characteristic.(20)
Synchronous gastric cancer is detected in 4~10% of all gas-
tric cancers.(3) In addition, the probability of patients treated with 
primary cancer developing a secondary cancer within 10 years is 
known to be approximately 10%.(21) The incidence of metachro-
nous cancer is higher in multiple gastric cancer than single gastric 
cancer,(22) and thus if predictive factors are identified, which 
would be of help to improve the prognosis of patients. In addition, 
if multiple lesions are overlooked at the time of initial treatment, 
the incidence of metachronous gastric cancer could be increased 
after treatment, which becomes an important issue.(23) The results 
of the current study show that in the MSI group, the incidence of 
multiple gastric center was higher. Therefore, it is thought that MSI 
is a factor exerting effects on the development of multiple cancer 
not only in HNPCC, but also in sporadic gastric cancer. 
According to the study reported by Nakashima,(20) in cases 
of MSI, the incidence of synchronous multiple gastric cancer was 
shown to be higher. Nevertheless, HNPCC was not excluded, and 
cancer in other organs, such as liver and colorectal cancer, were 
considered to be multiple cancer, and even MSI-L was considered 
as the MSI group. According to the study reported by Ribeiro,(13) 
the incidence of synchronous gastric cancer is high in MSI-H 
cases. However, in their study, hMLH1 was considered to be a 
marker for MSI-H, and instead of PCR-based mutational studies, 
the presence or absence of microsatellite changes was assessed by 
immunohistochemical staining.
It has been reported when MSI-positive cases are compared 
with -negative cases, generally, clinical as well as pathologic char-
acteristics are shown, and the prognosis is also different. Hence, 
in attempts to use it in clinics as markers for the early detection of 
cancer, as well as to predict prognosis or response, numerous stud-
ies have been conducted. The clinicopathologic characteristics of 
MSI colorectal cancer are well-characterized. In contrast, relatively 
few studies on gastric cancer have been conducted, and thus except 
few characteristics, none of them are characterized. Recently, it has 
been reported that in gastric cancer, the MSI cases generally occur 
in older age groups, and the development of cancer in the lower 
body, intestinal type, few lymph node metastasis regardless of T 
disease stage, and prognosis was relatively good.(24) 
Our study had limitations. The proportion of multiple gastric 
cancer in all cases of gastric cancer was 4/124 cases (3.1%), which 
was comparable to other studies conducted in other countries 
(4~15%) or slightly less.(3) This is thought due to the lack of inter-
ests on multiple lesions during the initial period of treatment, insuf-
ficient comprehensive record of resected specimens and histologic 
tests, which could be inferred from the finding that during 6 years 
of the entire study period, cases corresponding to 75% (3/4) were 
detected during the last 2 years. In addition, based on research re-
sults that generally, the onset time of metachronous gastric cancer 
after treatment is within an average of 10 years,(21) it is thought 
that 5.12±1.13 years of the follow-up observation period of our 
study is somewhat short to discuss the development of meta-
chronous gastric cancer. It is thought that in the future, studies on 
metachronous cancer and primary cancer in other organs in a large 
scale patient group are needed.
In summary, the results of the current study show that the MSI 
group has the characteristic of intestinal type as reported previ-
ously, and particularly, in sporadic gastric cancer, it is thought to be 
associated with the development of synchronous multiple cancer. 
Nevertheless, in order to apply it as a molecular biological factor 
that could predict the development of multiple gastric cancer, ad-
ditional studies are needed. Therefore, in the MSI group, the pos-
sibility of the presence of synchronous multiple cancer as well as 
the possibility of the development of metachronous cancer in the 
future should be monitored carefully and the follow-up observa-
tion is required. In addition, it could be speculated that in multiple 
and single gastric cancer, the genetic pathologic mechanism due to 
genetic factors different from each other is involved.
References
1.  Pedroni M, Tamassia MG, Percesepe A, Roncucci L, Benatti P, 
Lanza G Jr, et al. Microsatellite instability in multiple colorec-
tal tumors. Int J Cancer 1999;81:1-5.
2.  Sengupta SB, Yiu CY, Boulos PB, De Silva M, Sams VR, Del-
hanty JD. Genetic instability in patients with metachronous Kim SH, et al.
154
colorectal cancers. Br J Surg 1997;84:996-1000.
3.  Bae JM, Won YJ, Jung KW, Suh KA, Ahn DH, Park JG. An-
nual report of the central cancer registry in Korea-1999: 
based on registered data from 128 hospitals. Cancer Res Treat 
2001;33:367-372.
4.  Honmyo U, Misumi A, Murakami A, Haga Y, Akagi M. 
Clinicopathological analysis of synchronous multiple gastric 
carcinoma. Eur J Surg Oncol 1989;15:316-321.
5.  Kaibara N, Maeta M, Ikeguchi M. Patients with multiple 
primary gastric cancers tend to develop second primaries in 
organs other than the stomach. Surg Today 1993;23:186-188.
6.  Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch 
PM, et al. Genetics, natural history, tumor spectrum, and 
pathology of hereditary nonpolyposis colorectal cancer: an 
updated review. Gastroenterology 1993;104:1535-1549.
7.  Japanese Gastric Cancer Association. Japanese classifi  cation 
of gastric carcinoma - 2nd english edition -. Gastric Cancer 
1998;1:10-24.
8.  Lauren P. The two histological main types of gastric carci-
noma: diffuse and so-called intestinal-type carcinoma. An 
attempt at a HISTO-clinical classifi  cation. Acta Pathol Micro-
biol Scand 1965;64:31-49.
9.  Cleary JB, Kazarian KK, Mersheimer WL. Multiple primary 
cancer. Th   irty patients with three or more primary cancers. 
Am J Surg 1975;129:686-690.
10.  Suraweera N, Duval A, Reperant M, Vaury C, Furlan D, Leroy 
K, et al. Evaluation of tumor microsatellite instability using 
fi  ve quasimonomorphic mononucleotide repeats and penta-
plex PCR. Gastroenterology 2002;123:1804-1811.
11.  Boland CR, Th   ibodeau SN, Hamilton SR, Sidransky D, Eshle-
man JR, Burt RW, et al. A National Cancer Institute Work-
shop on Microsatellite Instability for cancer detection and 
familial predisposition: development of international criteria 
for the determination of microsatellite instability in colorectal 
cancer. Cancer Res 1998;58:5248-5257.
12.  Ahn YJ, Oh SJ, Song JW, Kang WH, Hyung WJ, Choi SH, 
et al. The clinicopathologic features and prognosis of mul-
tiple early gastric cancer. J Korean Gastric Cancer Assoc 
2008;8:198-203.
13.  Ribeiro U Jr, Jorge UM, Safatle-Ribeiro AV, Yagi OK, Scapula-
tempo C, Perez RO, et al. Clinicopathologic and immunohis-
tochemistry characterization of synchronous multiple prima-
ry gastric adenocarcinoma. J Gastrointest Surg 2007;11:233-
239.
14.  Bae JS, Lee JH, Ryu KW, Kim YW, Bae JM. Characteristics of 
synchronous cancers in gastric cancer patients. Cancer Res 
Treat 2006;38:25-29. 
15.  Tahara E. Molecular mechanism of stomach carcinogenesis. J 
Cancer Res Clin Oncol 1993;119:265-272.
16. Chong  JM, Fukayama M, Hayashi Y, Takizawa T, Koike M, 
Konishi M, et al. Microsatellite instability in the progression 
of gastric carcinoma. Cancer Res 1994;54:4595-4597.
17.  Sepulveda AR, Santos AC, Yamaoka Y, Wu L, Gutierrez O, 
Kim JG, et al. Marked diff  erences in the frequency of micro-
satellite instability in gastric cancer from diff  erent countries. 
Am J Gastroenterol 1999;94:3034-3038.
18.  Lim S, Lee HS, Kim HS, Kim YI, Kim WH. Alteration of E-
cadherin-mediated adhesion protein is common, but micro-
satellite instability is uncommon in young age gastric cancers. 
Histopathology 2003;42:128-136.
19.  Hayden JD, Cawkwell L, Quirke P, Dixon MF, Goldstone AR, 
Sue-Ling H, et al. Prognostic significance of microsatellite 
instability in patients with gastric carcinoma. Eur J Cancer 
1997;33:2342-2346.
20.  Nakashima H, Inoue H, Honda M, Shibuta K, Arinaga S, 
Mori M, et al. Th   e heterogeneity of microsatellite instability in 
multiple gastric cancers. Am J Gastroenterol 1995;90:653-656.
21. Oliveira C, Seruca R, Seixas M, Sobrinho-Simões M. The 
clinicopathological features of gastric carcinomas with micro-
satellite instability may be mediated by mutations of diff  erent 
"target genes": a study of the TGFbeta RII, IGFII R, and BAX 
genes. Am J Pathol 1998;153:1211-1219. 
22.  Miyoshi E, Haruma K, Hiyama T, Tanaka S, Yoshihara M, 
Shimamoto F, et al. Microsatellite instability is a genetic 
marker for the development of multiple gastric cancers. Int J 
Cancer 2001;95:350-353.
23.  Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, 
et al. Incidence, diagnosis and signifi  cance of multiple gastric 
cancer. Br J Surg 1995;82:1540-1543.
24.  Kim HC, Roh SA, Yook JH, Oh ST, Kim BS, Yu CS, et al. Mi-
crosatellite instability and promoter methylation of hMLH1 
in sporadic gastric carcinoma. J Korean Gastric Cancer Assoc 
2003;3:50-55.